Biotechnology
The Biotechnology industry has a total of 611 stocks, with a combined market cap of $1.07 trillion and total revenue of $105.52 billion.
Market Cap
1.07T
Revenue
105.52B
Profits
-42.83B
PE Ratio
n/a
Profit Margin
-40.59%
Dividend Yield
0.04%
611 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.10B | 1.82% | 87,010 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.38B | 1.01% | 89,513 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 59.18B | 0.49% | 38,464 | 3.21B |
| 4 | ARGX | argenx SE | 56.71B | 0.48% | 8,929 | 3.68B |
| 5 | INSM | Insmed Incorporated | 42.74B | 0.38% | 124,469 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 38.35B | -0.78% | 23,349 | 5.00B |
| 7 | BNTX | BioNTech SE | 23.71B | 1.67% | 54,720 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.18B | 0.08% | 115,196 | 2.35B |
| 9 | INCY | Incyte Corporation | 20.03B | 0.25% | 45,148 | 4.81B |
| 10 | GMAB | Genmab A/S | 18.61B | 1.07% | 62,348 | 3.85B |
| 11 | ROIV | Roivant Sciences Ltd. | 14.21B | 0.76% | 206,895 | 20.33M |
| 12 | RVMD | Revolution Medicines, Inc. | 13.53B | 0.14% | 75,778 | - |
| 13 | ASND | Ascendis Pharma A/S | 12.75B | -0.41% | 6,020 | 758.59M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 12.63B | 1.39% | 127,077 | 353.78M |
| 15 | SMMT | Summit Therapeutics Inc. | 12.53B | -1.22% | 359,697 | - |
| 16 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.37B | 0.45% | 591 | 740.64M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.98B | 1.16% | 92,210 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.31B | 0.57% | 176,912 | 2.29B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 10.73B | 0.51% | 55,731 | 4.16B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.65B | 0.03% | 212,814 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.17B | 0.84% | 64,247 | 3.09B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.40B | -2.02% | 165,248 | 7.07M |
| 23 | TECH | Bio-Techne Corporation | 9.22B | 0.75% | 67,814 | 1.22B |
| 24 | MRNA | Moderna, Inc. | 9.00B | 3.04% | 1,429,756 | 2.23B |
| 25 | HALO | Halozyme Therapeutics, Inc. | 8.11B | -0.04% | 45,708 | 1.24B |
| 26 | CORT | Corcept Therapeutics Incorporated | 7.96B | 0.89% | 11,018 | 741.17M |
| 27 | NUVL | Nuvalent, Inc. | 7.88B | 0.36% | 39,473 | - |
| 28 | CYTK | Cytokinetics, Incorporated | 7.78B | 0.24% | 83,800 | 87.21M |
| 29 | MRUS | Merus N.V. | 7.27B | -0.20% | 166,862 | 56.61M |
| 30 | AXSM | Axsome Therapeutics, Inc. | 7.23B | 0.13% | 21,525 | 561.26M |
| 31 | CDTX | Cidara Therapeutics, Inc. | 6.90B | -0.06% | 70,734 | 302.00K |
| 32 | CAI | Caris Life Sciences, Inc. | 6.80B | 0.25% | 62,961 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.78B | 0.85% | 34,396 | 174.33M |
| 34 | PCVX | Vaxcyte, Inc. | 6.30B | 0.92% | 70,847 | - |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.16B | 0.33% | 52,661 | 1.78B |
| 36 | KRYS | Krystal Biotech, Inc. | 5.93B | 0.16% | 11,286 | 373.16M |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 5.28B | 0.31% | 50,057 | 209.22M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.27B | -0.14% | 194,792 | - |
| 39 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.27B | 0.08% | 139,618 | 572.98M |
| 40 | ACLX | Arcellx, Inc. | 5.20B | 0.48% | 15,838 | 35.90M |
| 41 | LEGN | Legend Biotech Corporation | 5.11B | 0.58% | 51,703 | 909.05M |
| 42 | CRSP | CRISPR Therapeutics AG | 4.69B | -0.06% | 206,747 | 38.34M |
| 43 | KYMR | Kymera Therapeutics, Inc. | 4.65B | -0.04% | 315 | 43.74M |
| 44 | TGTX | TG Therapeutics, Inc. | 4.48B | 0.72% | 136,035 | 531.90M |
| 45 | AKRO | Akero Therapeutics, Inc. | 4.47B | 0.17% | 84,238 | - |
| 46 | CELC | Celcuity Inc. | 4.40B | 1.07% | 75,642 | - |
| 47 | APGE | Apogee Therapeutics, Inc. | 4.36B | 1.89% | 20,542 | - |
| 48 | NAMS | NewAmsterdam Pharma Company N.V. | 4.27B | -0.03% | 7,222 | 35.24M |
| 49 | CNTA | Centessa Pharmaceuticals plc | 4.09B | 1.67% | 85,612 | 15.00M |
| 50 | PRAX | Praxis Precision Medicines, Inc. | 4.06B | -1.08% | 67,634 | 7.46M |
| 51 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.01B | 0.69% | 48,552 | 1.54M |
| 52 | ACAD | ACADIA Pharmaceuticals Inc. | 3.93B | 1.53% | 71,787 | 1.05B |
| 53 | SRRK | Scholar Rock Holding Corporation | 3.93B | 1.25% | 71,377 | - |
| 54 | IMVT | Immunovant, Inc. | 3.91B | -2.15% | 161,763 | - |
| 55 | ADMA | ADMA Biologics, Inc. | 3.90B | 0.18% | 234,615 | 488.56M |
| 56 | VKTX | Viking Therapeutics, Inc. | 3.85B | -0.70% | 269,659 | - |
| 57 | BLTE | Belite Bio, Inc | 3.79B | -0.61% | 39,595 | - |
| 58 | MIRM | Mirum Pharmaceuticals, Inc. | 3.55B | -0.12% | 63,857 | 471.79M |
| 59 | IRON | Disc Medicine, Inc. | 3.44B | 0.86% | 19,262 | - |
| 60 | ARQT | Arcutis Biotherapeutics, Inc. | 3.39B | 1.17% | 177,840 | 317.93M |
| 61 | MLYS | Mineralys Therapeutics, Inc. | 3.30B | -0.36% | 74,563 | - |
| 62 | CGON | CG Oncology, Inc. | 3.30B | 0.41% | 71,301 | 2.17M |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 3.29B | 0.66% | 35,344 | 366.10M |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.14B | 0.77% | 56,777 | 7.50M |
| 65 | TVTX | Travere Therapeutics, Inc. | 3.13B | 0.75% | 39,116 | 435.83M |
| 66 | RARE | Ultragenyx Pharmaceutical Inc. | 3.05B | 1.56% | 37,346 | 630.60M |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.02B | 3.14% | 2,710 | 664.23M |
| 68 | IDYA | IDEAYA Biosciences, Inc. | 2.95B | 1.33% | 48,339 | 214.83M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.92B | 1.69% | 98,911 | - |
| 70 | FOLD | Amicus Therapeutics, Inc. | 2.91B | -0.16% | 287,349 | 598.70M |
| 71 | AAPG | Ascentage Pharma Group International | 2.86B | -0.58% | 4 | 54.52M |
| 72 | VRDN | Viridian Therapeutics, Inc. | 2.82B | 0.27% | 79,180 | 70.79M |
| 73 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.80B | 0.09% | 104,026 | 578.20M |
| 74 | OCUL | Ocular Therapeutix, Inc. | 2.58B | 3.50% | 187,756 | 55.78M |
| 75 | ADPT | Adaptive Biotechnologies Corporation | 2.56B | 2.70% | 353,513 | 252.75M |
| 76 | DNLI | Denali Therapeutics Inc. | 2.55B | 1.17% | 85,854 | - |
| 77 | APLS | Apellis Pharmaceuticals, Inc. | 2.50B | 0.92% | 35,124 | 1.02B |
| 78 | LQDA | Liquidia Corporation | 2.48B | -0.07% | 130,046 | 69.22M |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.44B | 0.92% | 41,701 | 98.68M |
| 80 | NUVB | Nuvation Bio Inc. | 2.40B | - | 784,228 | 26.75M |
| 81 | EWTX | Edgewise Therapeutics, Inc. | 2.35B | -0.04% | 50,400 | - |
| 82 | TERN | Terns Pharmaceuticals, Inc. | 2.32B | -1.55% | 258,960 | - |
| 83 | RCUS | Arcus Biosciences, Inc. | 2.29B | -0.05% | 136,820 | 240.00M |
| 84 | ZLAB | Zai Lab Limited | 2.22B | -0.89% | 52,343 | 441.63M |
| 85 | RXRX | Recursion Pharmaceuticals, Inc. | 2.11B | 5.32% | 4,396,272 | 43.69M |
| 86 | GPCR | Structure Therapeutics Inc. | 2.11B | 1.14% | 49,614 | - |
| 87 | BEAM | Beam Therapeutics Inc. | 2.07B | 1.60% | 110,206 | 55.70M |
| 88 | IBRX | ImmunityBio, Inc. | 2.03B | 1.98% | 517,957 | 82.56M |
| 89 | GLPG | Galapagos NV | 2.02B | 0.96% | 10,437 | 336.64M |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | 0.66% | 92,297 | 265.81M |
| 91 | IMCR | Immunocore Holdings plc | 1.96B | -0.33% | 6,187 | 379.59M |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 1.95B | 1.17% | 29,587 | 825.94M |
| 93 | VCEL | Vericel Corporation | 1.92B | 0.45% | 29,793 | 258.72M |
| 94 | MESO | Mesoblast Limited | 1.92B | 3.46% | 4,798 | 17.20M |
| 95 | ZBIO | Zenas BioPharma, Inc. | 1.87B | -0.24% | 18,601 | 15.00M |
| 96 | ZYME | Zymeworks Inc. | 1.85B | 3.69% | 153,561 | 134.48M |
| 97 | SYRE | Spyre Therapeutics, Inc. | 1.81B | -0.36% | 33,121 | - |
| 98 | VERA | Vera Therapeutics, Inc. | 1.79B | 0.72% | 87,805 | - |
| 99 | SION | Sionna Therapeutics, Inc. | 1.76B | 1.18% | 5,163 | - |
| 100 | JANX | Janux Therapeutics, Inc. | 1.75B | 1.49% | 25,225 | 10.00M |
| 101 | DNTH | Dianthus Therapeutics, Inc. | 1.74B | 0.54% | 18,361 | 3.08M |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 1.74B | 0.79% | 186,871 | 2.41B |
| 103 | QURE | uniQure N.V. | 1.71B | -1.43% | 102,522 | 15.75M |
| 104 | MAZE | Maze Therapeutics, Inc. | 1.68B | -1.69% | 23,091 | 2.50M |
| 105 | CLDX | Celldex Therapeutics, Inc. | 1.68B | 1.00% | 42,454 | 2.60M |
| 106 | IMNM | Immunome, Inc. | 1.66B | 3.08% | 51,584 | 9.68M |
| 107 | STOK | Stoke Therapeutics, Inc. | 1.64B | 2.94% | 40,663 | 205.63M |
| 108 | NRIX | Nurix Therapeutics, Inc. | 1.62B | 3.98% | 184,711 | 83.69M |
| 109 | PHVS | Pharvaris N.V. | 1.61B | 2.27% | 50,636 | - |
| 110 | INVA | Innoviva, Inc. | 1.57B | -0.80% | 56,996 | 388.52M |
| 111 | MNKD | MannKind Corporation | 1.55B | 1.41% | 169,536 | 313.79M |
| 112 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.50B | 0.88% | 42,765 | -665.00K |
| 113 | SNDX | Syndax Pharmaceuticals, Inc. | 1.48B | -0.23% | 162,090 | 111.30M |
| 114 | OLMA | Olema Pharmaceuticals, Inc. | 1.45B | -3.86% | 500,910 | - |
| 115 | PGEN | Precigen, Inc. | 1.42B | 3.08% | 268,763 | 6.31M |
| 116 | AGIO | Agios Pharmaceuticals, Inc. | 1.39B | -2.69% | 118,685 | 44.79M |
| 117 | TRVI | Trevi Therapeutics, Inc. | 1.37B | 0.38% | 81,529 | - |
| 118 | UPB | Upstream Bio, Inc. | 1.35B | 0.16% | 19,500 | 2.80M |
| 119 | ARDX | Ardelyx, Inc. | 1.30B | -3.24% | 342,151 | 398.23M |
| 120 | ORKA | Oruka Therapeutics, Inc. | 1.29B | -0.91% | 19,636 | - |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.29B | 0.97% | 17,013 | - |
| 122 | BHVN | Biohaven Ltd. | 1.28B | 0.31% | 191,508 | - |
| 123 | ELVN | Enliven Therapeutics, Inc. | 1.27B | 0.87% | 19,952 | - |
| 124 | IMTX | Immatics N.V. | 1.23B | 0.10% | 33,236 | 99.45M |
| 125 | TNGX | Tango Therapeutics, Inc. | 1.23B | 2.47% | 243,197 | 66.50M |
| 126 | MBX | MBX Biosciences, Inc. | 1.20B | -0.96% | 11,922 | - |
| 127 | URGN | UroGen Pharma Ltd. | 1.17B | 0.97% | 52,696 | 96.52M |
| 128 | INBX | Inhibrx Biosciences, Inc. | 1.17B | 0.93% | 8,762 | 1.40M |
| 129 | CVAC | CureVac N.V. | 1.16B | 0.59% | 68,955 | 599.54M |
| 130 | WVE | Wave Life Sciences Ltd. | 1.15B | 1.85% | 98,861 | 109.23M |
| 131 | PHAR | Pharming Group N.V. | 1.15B | 0.12% | 8,112 | 362.27M |
| 132 | SVRA | Savara Inc. | 1.14B | 1.07% | 90,482 | - |
| 133 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.14B | 0.51% | 38,672 | 42.34M |
| 134 | XERS | Xeris Biopharma Holdings, Inc. | 1.13B | -0.44% | 131,586 | 266.14M |
| 135 | NKTR | Nektar Therapeutics | 1.13B | 0.71% | 31,546 | 62.60M |
| 136 | TSHA | Taysha Gene Therapies, Inc. | 1.13B | 3.26% | 237,188 | 6.31M |
| 137 | RLAY | Relay Therapeutics, Inc. | 1.12B | 1.25% | 119,042 | 8.36M |
| 138 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | - | 48,471 | - |
| 139 | OCS | Oculis Holding AG | 1.11B | 0.10% | 429 | 992.00K |
| 140 | XNCR | Xencor, Inc. | 1.11B | -0.61% | 42,484 | 150.13M |
| 141 | PVLA | Palvella Therapeutics, Inc. | 1.09B | 0.50% | 6,416 | - |
| 142 | TYRA | Tyra Biosciences, Inc. | 1.08B | -3.57% | 34,492 | - |
| 143 | SEPN | Septerna, Inc. | 1.08B | 1.05% | 16,081 | 22.05M |
| 144 | MNMD | Mind Medicine (MindMed) Inc. | 1.07B | -0.09% | 125,140 | - |
| 145 | KOD | Kodiak Sciences Inc. | 1.04B | 0.71% | 27,790 | - |
| 146 | ABCL | AbCellera Biologics Inc. | 1.04B | 2.05% | 303,246 | 35.33M |
| 147 | NVAX | Novavax, Inc. | 1.04B | 2.41% | 392,324 | 1.06B |
| 148 | NBTX | Nanobiotix S.A. | 1.01B | 3.24% | 7,316 | 11.93M |
| 149 | ANAB | AnaptysBio, Inc. | 1.01B | -3.00% | 216,446 | 169.47M |
| 150 | PHAT | Phathom Pharmaceuticals, Inc. | 1.00B | 0.35% | 41,612 | 147.19M |
| 151 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 983.86M | 0.99% | 5,071 | - |
| 152 | MDXG | MiMedx Group, Inc. | 971.55M | 0.15% | 65,552 | 393.44M |
| 153 | KURA | Kura Oncology, Inc. | 965.89M | 1.09% | 116,638 | 104.03M |
| 154 | NTLA | Intellia Therapeutics, Inc. | 954.44M | 2.49% | 455,808 | 57.53M |
| 155 | FTRE | Fortrea Holdings Inc. | 945.25M | 1.89% | 58,375 | 2.76B |
| 156 | MLTX | MoonLake Immunotherapeutics | 913.58M | -1.54% | 198,631 | - |
| 157 | GLUE | Monte Rosa Therapeutics, Inc. | 903.51M | 2.63% | 50,310 | 181.54M |
| 158 | BCAX | Bicara Therapeutics Inc. | 897.33M | 1.24% | 29,653 | - |
| 159 | TBPH | Theravance Biopharma, Inc. | 896.40M | -1.17% | 45,413 | 80.33M |
| 160 | RZLT | Rezolute, Inc. | 880.91M | -1.55% | 126,442 | - |
| 161 | MRVI | Maravai LifeSciences Holdings, Inc. | 879.63M | 0.58% | 127,745 | 192.44M |
| 162 | LENZ | LENZ Therapeutics, Inc. | 877.68M | 1.19% | 22,579 | 17.50M |
| 163 | GHRS | GH Research PLC | 875.23M | 0.86% | 6,709 | - |
| 164 | CMPX | Compass Therapeutics, Inc. | 862.63M | - | 90,342 | 850.00K |
| 165 | IOVA | Iovance Biotherapeutics, Inc. | 861.42M | -0.46% | 599,895 | 250.43M |
| 166 | DAWN | Day One Biopharmaceuticals, Inc. | 856.31M | 0.60% | 42,297 | 133.67M |
| 167 | SANA | Sana Biotechnology, Inc. | 855.04M | -0.62% | 378,238 | - |
| 168 | AVBP | ArriVent BioPharma, Inc. | 827.69M | -0.05% | 14,063 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 817.38M | 1.19% | 90,147 | 14.61M |
| 170 | RIGL | Rigel Pharmaceuticals, Inc. | 800.47M | 0.59% | 36,904 | 282.08M |
| 171 | ERAS | Erasca, Inc. | 800.07M | 1.44% | 162,339 | - |
| 172 | ATAI | Atai Beckley N.V. | 795.20M | 1.37% | 228,248 | 3.02M |
| 173 | VIR | Vir Biotechnology, Inc. | 786.06M | 1.62% | 76,834 | 16.86M |
| 174 | CRMD | CorMedix Inc. | 769.77M | 0.51% | 385,198 | 214.30M |
| 175 | RAPT | RAPT Therapeutics, Inc. | 765.10M | 1.21% | 3,096 | - |
| 176 | VSTM | Verastem, Inc. | 764.10M | 0.92% | 206,146 | 13.38M |
| 177 | VALN | Valneva SE | 747.09M | 2.11% | 480 | 211.09M |
| 178 | ARVN | Arvinas, Inc. | 720.60M | 1.81% | 144,570 | 312.30M |
| 179 | ALMS | Alumis Inc. | 716.14M | -0.87% | 136,287 | 22.12M |
| 180 | ATXS | Astria Therapeutics, Inc. | 711.85M | 0.16% | 33,641 | 706.00K |
| 181 | GOSS | Gossamer Bio, Inc. | 708.26M | -1.61% | 314,704 | 44.05M |
| 182 | REPL | Replimune Group, Inc. | 705.99M | -0.11% | 90,739 | - |
| 183 | GERN | Geron Corporation | 705.38M | 0.45% | 540,266 | 183.40M |
| 184 | SPRY | ARS Pharmaceuticals, Inc. | 687.00M | 3.27% | 141,738 | 142.77M |
| 185 | GYRE | Gyre Therapeutics, Inc. | 682.13M | 0.20% | 5,762 | 107.27M |
| 186 | VTYX | Ventyx Biosciences, Inc. | 670.77M | -2.19% | 298,642 | - |
| 187 | KALV | KalVista Pharmaceuticals, Inc. | 655.18M | -0.45% | 50,233 | 1.43M |
| 188 | CTMX | CytomX Therapeutics, Inc. | 650.63M | 1.86% | 61,555 | 113.63M |
| 189 | PROK | ProKidney Corp. | 643.79M | 2.39% | 97,532 | 744.00K |
| 190 | CRVS | Corvus Pharmaceuticals, Inc. | 640.77M | 0.82% | 57,447 | - |
| 191 | LXEO | Lexeo Therapeutics, Inc. | 639.37M | -1.68% | 59,185 | - |
| 192 | PRME | Prime Medicine, Inc. | 626.71M | -4.07% | 311,246 | 5.98M |
| 193 | ANNX | Annexon, Inc. | 620.16M | 0.35% | 358,734 | - |
| 194 | MGTX | MeiraGTx Holdings plc | 603.28M | 0.87% | 44,378 | 27.42M |
| 195 | MPLT | MapLight Therapeutics, Inc. | 602.25M | 3.84% | 7,372 | - |
| 196 | FULC | Fulcrum Therapeutics, Inc. | 600.17M | 0.27% | 29,582 | 80.00M |
| 197 | FDMT | 4D Molecular Therapeutics, Inc. | 589.63M | -0.19% | 66,269 | 120.00K |
| 198 | OMER | Omeros Corporation | 588.47M | 0.85% | 118,994 | - |
| 199 | YDES | YD Bio Limited | 583.65M | -0.72% | 9,502 | 510.36K |
| 200 | IVA | Inventiva S.A. | 579.66M | 6.96% | 11,213 | 19.93M |
| 201 | IVVD | Invivyd, Inc. | 575.81M | 2.92% | 439,683 | 50.04M |
| 202 | ASMB | Assembly Biosciences, Inc. | 569.73M | -1.93% | 5,987 | 37.19M |
| 203 | RGNX | REGENXBIO Inc. | 560.90M | 1.93% | 41,219 | 161.32M |
| 204 | MNPR | Monopar Therapeutics Inc. | 554.65M | - | 3,997 | - |
| 205 | EVMN | Evommune, Inc. | 552.22M | -1.87% | 92,099 | 3.00M |
| 206 | PRTA | Prothena Corporation plc | 546.64M | 1.04% | 21,665 | 11.79M |
| 207 | NAGE | Niagen Bioscience, Inc. | 540.60M | 0.60% | 33,639 | 124.71M |
| 208 | CGEM | Cullinan Therapeutics, Inc. | 533.16M | 3.50% | 111,250 | - |
| 209 | JBIO | Jade Biosciences, Inc. | 519.85M | -1.57% | 11,480 | - |
| 210 | KROS | Keros Therapeutics, Inc. | 517.16M | 0.92% | 26,842 | 246.72M |
| 211 | ADCT | ADC Therapeutics SA | 500.46M | 1.25% | 40,616 | 75.21M |
| 212 | LXRX | Lexicon Pharmaceuticals, Inc. | 485.14M | 1.14% | 185,702 | 70.86M |
| 213 | DBVT | DBV Technologies S.A. | 482.53M | - | 7,843 | 5.50M |
| 214 | NBP | NovaBridge Biosciences | 478.35M | -0.95% | 16,573 | - |
| 215 | ALT | Altimmune, Inc. | 470.58M | 0.89% | 163,754 | 20.00K |
| 216 | ZVRA | Zevra Therapeutics, Inc. | 456.57M | -10.39% | 353,787 | 84.39M |
| 217 | DNA | Ginkgo Bioworks Holdings, Inc. | 452.98M | 1.92% | 81,305 | 180.61M |
| 218 | DSGN | Design Therapeutics, Inc. | 447.74M | -0.13% | 15,958 | - |
| 219 | IMRX | Immuneering Corporation | 447.47M | -0.86% | 53,774 | - |
| 220 | DRUG | Bright Minds Biosciences Inc. | 446.21M | -0.17% | 8,678 | - |
| 221 | BNTC | Benitec Biopharma Inc. | 442.58M | -0.53% | 7,168 | - |
| 222 | ABSI | Absci Corporation | 431.57M | 3.61% | 421,534 | 2.82M |
| 223 | ANRO | Alto Neuroscience, Inc. | 428.72M | -2.47% | 9,476 | - |
| 224 | BCYC | Bicycle Therapeutics plc | 428.35M | 0.08% | 8,189 | 28.34M |
| 225 | ENGN | enGene Holdings Inc. | 424.92M | -0.30% | 16,440 | - |
| 226 | LCTX | Lineage Cell Therapeutics, Inc. | 411.96M | 1.80% | 41,883 | 10.82M |
| 227 | NMRA | Neumora Therapeutics, Inc. | 402.68M | 2.12% | 55,979 | - |
| 228 | LBRX | LB Pharmaceuticals Inc | 399.47M | - | 246 | - |
| 229 | XOMA | XOMA Royalty Corporation | 394.22M | 0.02% | 3,865 | 47.11M |
| 230 | PRTC | PureTech Health plc | 387.27M | - | 1 | 6.39M |
| 231 | DMAC | DiaMedica Therapeutics Inc. | 381.73M | 1.52% | 31,568 | - |
| 232 | LYEL | Lyell Immunopharma, Inc. | 381.08M | 3.04% | 1,667 | 41.00K |
| 233 | GALT | Galectin Therapeutics Inc. | 380.39M | 2.79% | 33,488 | - |
| 234 | VTVT | vTv Therapeutics Inc. | 375.12M | -4.12% | 384 | 17.00K |
| 235 | FBRX | Forte Biosciences, Inc. | 366.37M | 0.46% | 25,999 | - |
| 236 | SLDB | Solid Biosciences Inc. | 359.17M | 3.36% | 52,092 | - |
| 237 | CLLS | Cellectis S.A. | 358.87M | 1.05% | 8,862 | 82.55M |
| 238 | PEPG | PepGen Inc. | 358.18M | 2.36% | 25,429 | - |
| 239 | OCGN | Ocugen, Inc. | 352.92M | 1.80% | 185,694 | 5.37M |
| 240 | ENTA | Enanta Pharmaceuticals, Inc. | 350.10M | - | 280,930 | 65.32M |
| 241 | AURA | Aura Biosciences, Inc. | 346.09M | 1.87% | 18,388 | - |
| 242 | TRDA | Entrada Therapeutics, Inc. | 344.27M | 4.69% | 36,615 | 61.52M |
| 243 | PALI | Palisade Bio, Inc. | 342.71M | -1.71% | 697,952 | - |
| 244 | TECX | Tectonic Therapeutic, Inc. | 337.08M | -0.28% | 11,720 | - |
| 245 | AUTL | Autolus Therapeutics plc | 330.02M | 0.81% | 163,295 | 51.13M |
| 246 | CTNM | Contineum Therapeutics, Inc. | 324.51M | -9.00% | 166,687 | - |
| 247 | AVTX | Avalo Therapeutics, Inc. | 322.78M | 0.34% | 227 | 192.00K |
| 248 | NGNE | Neurogene Inc. | 322.03M | 1.91% | 7,353 | 925.00K |
| 249 | XFOR | X4 Pharmaceuticals, Inc. | 320.11M | -1.05% | 3,806 | 33.98M |
| 250 | EPRX | Eupraxia Pharmaceuticals Inc. | 319.52M | 1.45% | 1,061 | - |
| 251 | KYTX | Kyverna Therapeutics, Inc. | 317.61M | -2.53% | 22,002 | - |
| 252 | TENX | Tenax Therapeutics, Inc. | 315.64M | 0.97% | 4,121 | - |
| 253 | RCKT | Rocket Pharmaceuticals, Inc. | 308.97M | 0.53% | 123,912 | - |
| 254 | DRTS | Alpha Tau Medical Ltd. | 299.35M | 1.44% | 1,421 | - |
| 255 | PYXS | Pyxis Oncology, Inc. | 295.44M | 4.75% | 57,678 | 2.82M |
| 256 | LRMR | Larimar Therapeutics, Inc. | 291.86M | 1.19% | 58,480 | - |
| 257 | ACIU | AC Immune SA | 288.91M | 0.34% | 5,334 | 5.48M |
| 258 | ALDX | Aldeyra Therapeutics, Inc. | 288.18M | 1.27% | 46,252 | - |
| 259 | MREO | Mereo BioPharma Group plc | 287.23M | 0.84% | 103,320 | 500.00K |
| 260 | CYBN | Cybin Inc. | 286.95M | -1.71% | 18,249 | - |
| 261 | RLMD | Relmada Therapeutics, Inc. | 285.27M | -9.95% | 208,110 | - |
| 262 | VNDA | Vanda Pharmaceuticals Inc. | 282.48M | -1.24% | 57,534 | 212.07M |
| 263 | SLN | Silence Therapeutics plc | 279.03M | -6.97% | 2,872 | 25.83M |
| 264 | ALLO | Allogene Therapeutics, Inc. | 276.42M | -0.81% | 156,481 | 22.00K |
| 265 | AVXL | Anavex Life Sciences Corp. | 275.72M | 1.26% | 241,022 | - |
| 266 | FENC | Fennec Pharmaceuticals Inc. | 268.77M | 0.38% | 21,316 | 38.79M |
| 267 | NAUT | Nautilus Biotechnology, Inc. | 266.50M | -0.24% | 4,851 | - |
| 268 | ACRS | Aclaris Therapeutics, Inc. | 264.36M | 1.24% | 60,839 | 15.74M |
| 269 | CAPR | Capricor Therapeutics, Inc. | 262.42M | 0.88% | 101,374 | 11.13M |
| 270 | FHTX | Foghorn Therapeutics Inc. | 259.57M | - | 12,826 | 24.52M |
| 271 | ARMP | Armata Pharmaceuticals, Inc. | 259.40M | -0.14% | 3,612 | 5.05M |
| 272 | CBIO | Crescent Biopharma, Inc. | 256.30M | 0.23% | 876 | - |
| 273 | TARA | Protara Therapeutics, Inc. | 254.68M | 2.48% | 88,174 | - |
| 274 | OBIO | Orchestra BioMed Holdings, Inc. | 250.14M | - | 7,301 | 2.82M |
| 275 | PBYI | Puma Biotechnology, Inc. | 248.43M | 1.86% | 23,784 | 212.00M |
| 276 | IMMP | Immutep Limited | 247.54M | 2.96% | 1,346 | 3.31M |
| 277 | CADL | Candel Therapeutics, Inc. | 242.65M | - | 33,937 | - |
| 278 | ABEO | Abeona Therapeutics Inc. | 240.61M | 5.21% | 235,300 | 400.00K |
| 279 | ZURA | Zura Bio Limited | 239.94M | 0.54% | 8,890 | - |
| 280 | MIST | Milestone Pharmaceuticals Inc. | 238.72M | 1.73% | 259,681 | - |
| 281 | OABI | OmniAb, Inc. | 234.65M | -2.40% | 43,603 | 21.09M |
| 282 | AVIR | Atea Pharmaceuticals, Inc. | 234.38M | - | 35,569 | - |
| 283 | EDIT | Editas Medicine, Inc. | 234.28M | -2.83% | 139,732 | 46.38M |
| 284 | CCCC | C4 Therapeutics, Inc. | 233.56M | 1.26% | 23,763 | 30.11M |
| 285 | VYGR | Voyager Therapeutics, Inc. | 229.07M | 0.73% | 28,971 | 31.32M |
| 286 | SLS | SELLAS Life Sciences Group, Inc. | 218.65M | 5.14% | 491,684 | - |
| 287 | MDWD | MediWound Ltd. | 218.62M | 1.13% | 13,483 | 20.93M |
| 288 | SGMT | Sagimet Biosciences Inc. | 218.55M | -7.57% | 358,124 | - |
| 289 | PRQR | ProQR Therapeutics N.V. | 215.96M | -0.49% | 2,970 | 18.86M |
| 290 | BDTX | Black Diamond Therapeutics, Inc. | 215.08M | -0.92% | 113,984 | 70.00M |
| 291 | HUMA | Humacyte, Inc. | 211.62M | 0.89% | 389,247 | 1.57M |
| 292 | ACHV | Achieve Life Sciences, Inc. | 211.34M | 2.32% | 1,044,192 | - |
| 293 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 210.46M | 2.57% | 9,312 | - |
| 294 | CABA | Cabaletta Bio, Inc. | 205.04M | -0.93% | 16,946 | - |
| 295 | AARD | Aardvark Therapeutics, Inc. | 201.40M | -1.91% | 1,075 | - |
| 296 | TNYA | Tenaya Therapeutics, Inc. | 194.81M | 0.86% | 353,558 | - |
| 297 | RANI | Rani Therapeutics Holdings, Inc. | 191.99M | 2.60% | 620,393 | 1.20M |
| 298 | TLSA | Tiziana Life Sciences Ltd | 191.31M | -0.31% | 47,004 | - |
| 299 | HRTX | Heron Therapeutics, Inc. | 189.78M | -1.90% | 186,630 | 155.10M |
| 300 | RNAC | Cartesian Therapeutics, Inc. | 188.01M | 1.12% | 11,689 | 1.09M |
| 301 | GUTS | Fractyl Health, Inc. | 186.38M | 5.43% | 280,240 | 3.00K |
| 302 | TNXP | Tonix Pharmaceuticals Holding Corp. | 185.01M | 0.45% | 75,488 | 10.30M |
| 303 | SABS | SAB Biotherapeutics, Inc. | 183.29M | 1.32% | 9,358 | 114.70K |
| 304 | ARCT | Arcturus Therapeutics Holdings Inc. | 179.00M | 6.78% | 92,704 | 97.60M |
| 305 | VTGN | Vistagen Therapeutics, Inc. | 177.73M | 1.12% | 22,667 | 721.00K |
| 306 | GNLX | Genelux Corporation | 174.55M | - | 8,663 | 8.00K |
| 307 | IPHA | Innate Pharma S.A. | 170.59M | 1.65% | 3,995 | 14.84M |
| 308 | CNTB | Connect Biopharma Holdings Limited | 166.59M | -5.40% | 26,854 | 762.00K |
| 309 | CAMP | Camp4 Therapeutics Corporation | 166.43M | 1.14% | 1,040 | 3.80M |
| 310 | CRBU | Caribou Biosciences, Inc. | 165.44M | 1.14% | 78,893 | 9.30M |
| 311 | ETHZ | ETHZilla Corporation | 159.88M | - | 99,071 | 4.11M |
| 312 | MCRB | Seres Therapeutics, Inc. | 159.04M | -18.99% | 144,954 | 351.00K |
| 313 | NVCT | Nuvectis Pharma, Inc. | 151.13M | 0.34% | 5,077 | - |
| 314 | MOLN | Molecular Partners AG | 149.76M | - | 4 | 856.30K |
| 315 | AGEN | Agenus Inc. | 145.22M | -0.47% | 6,305 | 106.83M |
| 316 | ANIX | Anixa Biosciences, Inc. | 145.00M | 0.11% | 28,320 | - |
| 317 | ELTX | Elicio Therapeutics, Inc. | 142.95M | 2.38% | 7,187 | - |
| 318 | VOR | Vor Biopharma Inc. | 142.87M | 2.04% | 69,611 | - |
| 319 | CGEN | Compugen Ltd. | 142.17M | - | 840 | 6.90M |
| 320 | ACTU | Actuate Therapeutics, Inc. | 141.32M | -0.16% | 2,317 | - |
| 321 | SAVA | Cassava Sciences, Inc. | 141.06M | 11.03% | 536,501 | - |
| 322 | CDXS | Codexis, Inc. | 140.91M | -0.64% | 93,594 | 52.93M |
| 323 | SGMO | Sangamo Therapeutics, Inc. | 140.55M | 8.49% | 37,558,973 | 32.88M |
| 324 | PLX | Protalix BioTherapeutics, Inc. | 139.93M | - | 39,451 | 61.84M |
| 325 | EXOZ | eXoZymes, Inc. | 138.22M | 3.65% | 192 | -700.00 |
| 326 | IMMX | Immix Biopharma, Inc. | 137.67M | 1.99% | 22,242 | - |
| 327 | MRSN | Mersana Therapeutics, Inc. | 137.49M | 0.15% | 2,137 | 33.18M |
| 328 | CHRS | Coherus Oncology, Inc. | 136.58M | 2.73% | 95,831 | 277.73M |
| 329 | ALEC | Alector, Inc. | 133.16M | 1.67% | 52,011 | 69.05M |
| 330 | IRD | Opus Genetics, Inc. | 132.41M | -0.52% | 19,359 | 14.63M |
| 331 | CRDF | Cardiff Oncology, Inc. | 132.03M | - | 118,973 | 501.00K |
| 332 | PRLD | Prelude Therapeutics Incorporated | 130.19M | -1.25% | 11,343 | 10.50M |
| 333 | SPRO | Spero Therapeutics, Inc. | 126.76M | -0.44% | 47,169 | 40.55M |
| 334 | ACOG | Alpha Cognition Inc. | 126.76M | - | 273 | 7.43M |
| 335 | KLRS | Kalaris Therapeutics, Inc. | 125.59M | -2.68% | 40,213 | - |
| 336 | COYA | Coya Therapeutics, Inc. | 125.55M | 0.33% | 890 | 3.99M |
| 337 | NKTX | Nkarta, Inc. | 122.88M | - | 43,547 | - |
| 338 | CNTX | Context Therapeutics Inc. | 121.51M | - | 3,872 | - |
| 339 | IKT | Inhibikase Therapeutics, Inc. | 121.03M | 5.23% | 941,530 | 1.00 |
| 340 | INO | Inovio Pharmaceuticals, Inc. | 120.57M | 1.45% | 74,212 | 182.34K |
| 341 | STTK | Shattuck Labs, Inc. | 120.23M | -1.55% | 4,361 | 1.00M |
| 342 | DTIL | Precision BioSciences, Inc. | 119.40M | -0.40% | 3,238 | 698.00K |
| 343 | CLYM | Climb Bio, Inc. | 119.32M | 1.16% | 10,123 | - |
| 344 | FATE | Fate Therapeutics, Inc. | 117.66M | 2.00% | 145,895 | 7.14M |
| 345 | CGTX | Cognition Therapeutics, Inc. | 117.40M | - | 152,874 | - |
| 346 | ENTX | Entera Bio Ltd. | 116.44M | -1.16% | 13,747 | 124.00K |
| 347 | NBY | NovaBay Pharmaceuticals, Inc. | 116.27M | -6.80% | 10,912 | 10.30M |
| 348 | SRZN | Surrozen, Inc. | 115.29M | -2.11% | 1,842 | 3.60M |
| 349 | NTHI | NeOnc Technologies Holdings, Inc. | 114.19M | 0.51% | 22,131 | 59.99K |
| 350 | QNCX | Quince Therapeutics, Inc. | 114.15M | 0.49% | 48,018 | - |
| 351 | GLSI | Greenwich LifeSciences, Inc. | 112.91M | -0.12% | 3,060 | - |
| 352 | UNCY | Unicycive Therapeutics, Inc. | 112.83M | -0.38% | 19,144 | - |
| 353 | SEER | Seer, Inc. | 108.23M | - | 26,807 | 16.38M |
| 354 | SPRB | Spruce Biosciences, Inc. | 108.11M | -1.57% | 36,957 | 697.00K |
| 355 | ELDN | Eledon Pharmaceuticals, Inc. | 105.21M | 0.72% | 158,288 | - |
| 356 | SLGL | Sol-Gel Technologies Ltd. | 104.44M | 4.87% | 834 | 18.97M |
| 357 | ONCY | Oncolytics Biotech Inc. | 104.01M | -1.17% | 60,826 | - |
| 358 | GANX | Gain Therapeutics, Inc. | 102.88M | - | 35,123 | - |
| 359 | ORMP | Oramed Pharmaceuticals Inc. | 98.31M | 2.07% | 7,574 | 2.00M |
| 360 | ANVS | Annovis Bio, Inc. | 98.06M | -4.64% | 508,980 | - |
| 361 | KPTI | Karyopharm Therapeutics Inc. | 98.04M | -0.17% | 15,491 | 142.53M |
| 362 | WHWK | Whitehawk Therapeutics, Inc. | 98.03M | 4.52% | 5,992 | 14.38M |
| 363 | ATRA | Atara Biotherapeutics, Inc. | 97.41M | 2.19% | 91,067 | 151.93M |
| 364 | ATOS | Atossa Therapeutics, Inc. | 97.20M | 0.07% | 142,337 | - |
| 365 | VANI | Vivani Medical, Inc. | 97.03M | -1.48% | 16,892 | - |
| 366 | ACET | Adicet Bio, Inc. | 95.89M | 2.68% | 11,323 | - |
| 367 | ZNTL | Zentalis Pharmaceuticals, Inc. | 95.01M | 1.15% | 13,272 | 26.87M |
| 368 | ANEB | Anebulo Pharmaceuticals, Inc. | 94.08M | - | 6 | - |
| 369 | ABOS | Acumen Pharmaceuticals, Inc. | 93.89M | -0.64% | 3,866 | - |
| 370 | PLRX | Pliant Therapeutics, Inc. | 93.71M | -2.24% | 26,012 | - |
| 371 | ADVM | Adverum Biotechnologies, Inc. | 92.28M | -0.24% | 5,291 | 1.00M |
| 372 | RPTX | Repare Therapeutics Inc. | 91.50M | 1.43% | 29,614 | 11.87M |
| 373 | CSBR | Champions Oncology, Inc. | 91.42M | -0.45% | - | 56.88M |
| 374 | VXRT | Vaxart, Inc. | 90.31M | -3.08% | 398,487 | 148.20M |
| 375 | OVID | Ovid Therapeutics Inc. | 89.37M | 2.87% | 121,058 | 6.61M |
| 376 | PTHS | Pelthos Therapeutics Inc. | 88.79M | - | 81 | 7.41M |
| 377 | MGNX | MacroGenics, Inc. | 86.66M | - | 36,835 | 127.63M |
| 378 | COEP | Coeptis Therapeutics Holdings, Inc. | 86.56M | -0.61% | 4,817 | 501.00K |
| 379 | CRVO | CervoMed Inc. | 85.03M | 2.00% | 8,259 | 6.16M |
| 380 | TIL | Instil Bio, Inc. | 83.32M | 2.63% | 2,239 | - |
| 381 | IMUX | Immunic, Inc. | 82.73M | 0.04% | 38,191 | - |
| 382 | OTLK | Outlook Therapeutics, Inc. | 82.62M | -1.06% | 240,173 | 1.51M |
| 383 | HYFT | MindWalk Holdings Corp. | 82.15M | 0.56% | 19,397 | 18.21M |
| 384 | HURA | TuHURA Biosciences, Inc. | 82.01M | 0.95% | 1,459 | - |
| 385 | ADAG | Adagene Inc. | 82.01M | -1.69% | 3,172 | 103.20K |
| 386 | TVGN | Tevogen Bio Holdings Inc. | 81.16M | -1.16% | 12,136 | - |
| 387 | TTRX | Turn Therapeutics Inc. | 79.80M | - | 3,849 | - |
| 388 | IMA | ImageneBio, Inc. | 78.98M | 3.71% | 8,838 | 800.00K |
| 389 | IFRX | InflaRx N.V. | 77.91M | - | 69,539 | 73.73K |
| 390 | BYSI | BeyondSpring Inc. | 77.84M | 10.92% | 6,588 | 1.88M |
| 391 | THAR | Tharimmune, Inc. | 77.80M | -1.33% | 16,171 | - |
| 392 | ARTV | Artiva Biotherapeutics, Inc. | 76.95M | -1.10% | 4,631 | 251.00K |
| 393 | OKYO | OKYO Pharma Limited | 76.35M | 6.28% | 16,512 | - |
| 394 | FBIO | Fortress Biotech, Inc. | 75.58M | 0.40% | 16,906 | 62.30M |
| 395 | ALXO | ALX Oncology Holdings Inc. | 73.74M | - | 35,001 | - |
| 396 | ACRV | Acrivon Therapeutics, Inc. | 72.64M | 1.86% | 19,748 | - |
| 397 | PMVP | PMV Pharmaceuticals, Inc. | 71.57M | 2.67% | 1,210 | - |
| 398 | STRO | Sutro Biopharma, Inc. | 71.43M | -0.90% | 6,524 | 105.65M |
| 399 | MNOV | MediciNova, Inc. | 70.93M | 1.85% | 14,964 | 257.92K |
| 400 | XBIT | XBiotech Inc. | 69.51M | 2.70% | 3,919 | - |
| 401 | BCAB | BioAtla, Inc. | 69.37M | 1.72% | 408,566 | 11.00M |
| 402 | BMEA | Biomea Fusion, Inc. | 68.59M | -2.99% | 200,704 | - |
| 403 | CBUS | Cibus, Inc. | 67.85M | -0.79% | 18,888 | 3.79M |
| 404 | PSTV | Plus Therapeutics, Inc. | 67.53M | 0.61% | 702,790 | 5.26M |
| 405 | EQ | Equillium, Inc. | 65.16M | 5.94% | 24,311 | 4.39M |
| 406 | ATYR | aTyr Pharma, Inc. | 64.20M | 0.58% | 193,873 | 190.00K |
| 407 | ATHE | Alterity Therapeutics Limited | 63.31M | - | 4 | 3.57M |
| 408 | ABVC | ABVC BioPharma, Inc. | 62.70M | - | 2,223 | 797.92K |
| 409 | ESLA | Estrella Immunopharma, Inc. | 62.31M | 1.85% | 14,116 | - |
| 410 | LITS | Lite Strategy, Inc. | 61.80M | -1.18% | 195,330 | - |
| 411 | NTRB | Nutriband Inc. | 60.32M | -0.40% | 180 | 2.58M |
| 412 | KRRO | Korro Bio, Inc. | 58.58M | 3.84% | 124,854 | 7.37M |
| 413 | PYPD | PolyPid Ltd. | 58.22M | -3.58% | 2,611 | - |
| 414 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 57.54M | 4.19% | 930,421 | - |
| 415 | MGX | Metagenomi, Inc. | 57.45M | 1.32% | 23,387 | 30.91M |
| 416 | TCRX | TScan Therapeutics, Inc. | 55.48M | -0.77% | 56,424 | 8.42M |
| 417 | OSTX | OS Therapies Incorporated | 54.99M | 1.23% | 11,120 | - |
| 418 | ALGS | Aligos Therapeutics, Inc. | 49.97M | -1.69% | 2,265 | 2.65M |
| 419 | ANL | Adlai Nortye Ltd. | 49.45M | -6.29% | - | 1.94M |
| 420 | NRXP | NRx Pharmaceuticals, Inc. | 48.73M | 0.99% | 29,784 | 242.00K |
| 421 | JSPR | Jasper Therapeutics, Inc. | 48.41M | -1.70% | 93,028 | - |
| 422 | INKT | MiNK Therapeutics, Inc. | 48.37M | -1.70% | 4,117 | - |
| 423 | CVM | CEL-SCI Corporation | 48.36M | -1.14% | 18,535 | - |
| 424 | CELU | Celularity Inc. | 48.16M | -0.58% | 877 | 40.58M |
| 425 | IBO | Impact BioMedical Inc. | 47.08M | - | 2,721 | 25.00K |
| 426 | SNTI | Senti Biosciences, Inc. | 46.53M | -2.21% | 5,654 | - |
| 427 | IOBT | IO Biotech, Inc. | 46.18M | -5.13% | 49,254 | - |
| 428 | LVTX | LAVA Therapeutics N.V. | 45.77M | - | - | 4.99M |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 45.73M | -4.32% | 4,794,945 | - |
| 430 | CALC | CalciMedica, Inc. | 45.68M | 0.32% | 190 | - |
| 431 | KZR | Kezar Life Sciences, Inc. | 44.96M | -0.32% | 1,833 | - |
| 432 | GNTA | Genenta Science S.p.A. | 44.52M | 9.20% | 14,636 | - |
| 433 | GRCE | Grace Therapeutics, Inc. | 44.36M | - | 1 | - |
| 434 | EVAX | Evaxion A/S | 43.92M | -0.94% | 4,975 | 7.65M |
| 435 | JUNS | Jupiter Neurosciences, Inc. | 43.19M | 0.81% | 2,210 | - |
| 436 | CUE | Cue Biopharma, Inc. | 43.07M | 1.15% | 5,632 | 7.10M |
| 437 | PDSB | PDS Biotechnology Corporation | 42.14M | 1.85% | 29,443 | - |
| 438 | ICCC | ImmuCell Corporation | 41.61M | - | 31 | 27.77M |
| 439 | IPSC | Century Therapeutics, Inc. | 41.45M | -3.24% | 26,378 | 113.34M |
| 440 | SER | Serina Therapeutics, Inc. | 41.38M | 3.19% | 606 | 116.00K |
| 441 | HOWL | Werewolf Therapeutics, Inc. | 41.26M | -0.54% | 116,804 | 1.14M |
| 442 | SKYE | Skye Bioscience, Inc. | 40.55M | 1.20% | 3,741 | - |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 39.93M | -0.78% | 2,967 | 90.00K |
| 444 | XLO | Xilio Therapeutics, Inc. | 39.38M | - | 3,111 | 31.80M |
| 445 | BTAI | BioXcel Therapeutics, Inc. | 39.37M | 0.56% | 63,470 | 752.00K |
| 446 | INMB | INmune Bio, Inc. | 39.35M | -0.67% | 32,622 | 50.00K |
| 447 | RADX | Radiopharm Theranostics Limited | 38.67M | 2.45% | 409 | 8.20M |
| 448 | APLT | Applied Therapeutics, Inc. | 38.24M | -5.59% | 1,825,702 | 1.00M |
| 449 | VRCA | Verrica Pharmaceuticals Inc. | 38.07M | 0.25% | 7,212 | 30.83M |
| 450 | OKUR | OnKure Therapeutics, Inc. | 36.58M | 3.05% | 5,191 | - |
| 451 | PLUR | Pluri Inc. | 36.55M | 1.28% | 3,841 | 1.33M |
| 452 | MURA | Mural Oncology plc | 36.21M | -0.48% | 16,418 | - |
| 453 | TVRD | Tvardi Therapeutics, Inc. | 35.46M | -1.05% | 6,087 | - |
| 454 | DYAI | Dyadic International, Inc. | 34.74M | 3.77% | 32,980 | 3.34M |
| 455 | VERU | Veru Inc. | 34.67M | -3.14% | 1,392 | 16.89M |
| 456 | LNAI | Lunai Bioworks Inc. | 34.30M | 2.78% | 91,191 | - |
| 457 | GBIO | Generation Bio Co. | 34.16M | 1.20% | 156 | 15.27M |
| 458 | MAIA | MAIA Biotechnology, Inc. | 33.94M | 5.21% | 4,676 | - |
| 459 | FGEN | FibroGen, Inc. | 33.62M | 0.12% | 898 | 8.30M |
| 460 | LTRN | Lantern Pharma Inc. | 32.99M | -1.67% | 15,076 | - |
| 461 | RNTX | Rein Therapeutics Inc. | 32.63M | 1.45% | 44,151 | - |
| 462 | NXTC | NextCure, Inc. | 32.19M | 3.15% | 7,695 | - |
| 463 | APLM | Apollomics, Inc. | 31.48M | -0.54% | 690 | 198.00K |
| 464 | KLTO | Klotho Neurosciences, Inc. | 30.32M | 3.98% | 1,375,673 | - |
| 465 | HYPD | Hyperion DeFi, Inc. | 29.83M | -3.59% | 35,196 | 345.32K |
| 466 | RNXT | RenovoRx, Inc. | 29.26M | 2.57% | 54,105 | 928.00K |
| 467 | ANTX | AN2 Therapeutics, Inc. | 29.05M | -1.85% | 260 | - |
| 468 | NERV | Minerva Neurosciences, Inc. | 28.81M | -5.07% | 8,325 | - |
| 469 | IGC | IGC Pharma, Inc. | 28.52M | -0.70% | 37,405 | 1.11M |
| 470 | BRNS | Barinthus Biotherapeutics plc | 28.17M | -0.92% | 2,081 | 14.97M |
| 471 | CLGN | CollPlant Biotechnologies Ltd. | 27.21M | - | 7,402 | 2.40M |
| 472 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 27.04M | -10.20% | 52,586 | 1.00M |
| 473 | NRSN | NeuroSense Therapeutics Ltd. | 26.80M | - | 10,689 | - |
| 474 | XCUR | Exicure, Inc. | 26.32M | -1.20% | 17,363 | 500.00K |
| 475 | NRXS | NeurAxis, Inc. | 26.10M | -2.39% | 5,878 | 3.36M |
| 476 | RLYB | Rallybio Corporation | 25.77M | - | 101 | 674.00K |
| 477 | CASI | CASI Pharmaceuticals, Inc. | 25.27M | 3.36% | 762 | 26.85M |
| 478 | LIXT | Lixte Biotechnology Holdings, Inc. | 24.93M | 0.69% | 669 | - |
| 479 | BOLD | Boundless Bio, Inc. | 24.85M | - | 17,501 | - |
| 480 | NNVC | NanoViricides, Inc. | 24.64M | 2.42% | 20,722 | - |
| 481 | LEXX | Lexaria Bioscience Corp. | 24.24M | -1.36% | 4,684 | 615.92K |
| 482 | QTTB | Q32 Bio Inc. | 23.99M | 1.04% | 16,167 | - |
| 483 | PASG | Passage Bio, Inc. | 23.49M | -0.67% | 2,650 | - |
| 484 | DARE | Daré Bioscience, Inc. | 23.43M | 0.61% | 9,459 | -57.13K |
| 485 | NEUP | Neuphoria Therapeutics Inc. | 23.39M | 3.32% | 3,364 | 15.65M |
| 486 | CING | Cingulate Inc. | 23.31M | -0.29% | 2,854 | - |
| 487 | INTS | Intensity Therapeutics, Inc. | 23.13M | 1.32% | 102,437 | - |
| 488 | QNTM | Quantum BioPharma Ltd. | 23.08M | -0.24% | 4,788 | - |
| 489 | CVKD | Cadrenal Therapeutics, Inc. | 22.83M | -2.65% | 2,812 | - |
| 490 | ENLV | Enlivex Therapeutics Ltd. | 22.65M | 2.19% | 16,897 | - |
| 491 | GLTO | Galecto, Inc. | 22.63M | -1.73% | 7,071 | - |
| 492 | IBIO | iBio, Inc. | 22.46M | 0.38% | 162,001 | 500.00K |
| 493 | PTN | Palatin Technologies, Inc. | 22.39M | 0.90% | 581 | 8.85M |
| 494 | PMN | ProMIS Neurosciences, Inc. | 21.86M | 6.39% | 4,319 | - |
| 495 | MBRX | Moleculin Biotech, Inc. | 21.67M | 1.00% | 78,827 | - |
| 496 | GDTC | CytoMed Therapeutics Limited | 20.77M | 0.01% | 5,299 | 573.19K |
| 497 | CTXR | Citius Pharmaceuticals, Inc. | 20.13M | 10.10% | 159,175 | - |
| 498 | ITRM | Iterum Therapeutics plc | 19.70M | 10.81% | 356,607 | 390.00K |
| 499 | SYBX | Synlogic, Inc. | 18.72M | - | 56 | 8.00K |
| 500 | LIMN | Liminatus Pharma, Inc. | 18.44M | -35.10% | 1,347,415 | - |
| 501 | APVO | Aptevo Therapeutics Inc. | 18.37M | 0.93% | 72,158 | - |
| 502 | ATHA | Athira Pharma, Inc. | 17.91M | - | - | - |
| 503 | LPCN | Lipocine Inc. | 17.60M | 0.63% | 686 | 4.32M |
| 504 | TRAW | Traws Pharma, Inc. | 17.58M | 2.80% | 3,829 | 2.85M |
| 505 | LSTA | Lisata Therapeutics, Inc. | 17.29M | -1.51% | 3,201 | 1.07M |
| 506 | MTVA | MetaVia Inc. | 16.87M | 5.05% | 13,365 | - |
| 507 | AKTX | Akari Therapeutics, Plc | 16.80M | 1.67% | 10,969 | - |
| 508 | FBLG | FibroBiologics, Inc. | 16.78M | 0.49% | 23,671 | - |
| 509 | MRKR | Marker Therapeutics, Inc. | 16.67M | 0.58% | 46,224 | 4.69M |
| 510 | ABP | Abpro Holdings, Inc. | 16.32M | -3.92% | 273 | 183.00K |
| 511 | HOTH | Hoth Therapeutics, Inc. | 16.13M | 0.97% | 77,509 | - |
| 512 | PULM | Pulmatrix, Inc. | 15.92M | -6.54% | 1,912 | 3.00K |
| 513 | PCSA | Processa Pharmaceuticals, Inc. | 15.75M | 2.06% | 51,544 | - |
| 514 | TPST | Tempest Therapeutics, Inc. | 15.74M | -3.67% | 50,142 | - |
| 515 | CANF | Can-Fite BioPharma Ltd. | 15.72M | -6.88% | 923,216 | 560.00K |
| 516 | OSRH | OSR Holdings, Inc. | 15.49M | 32.30% | 31,008,541 | -90.52K |
| 517 | BLRX | BioLineRx Ltd. | 15.23M | -6.51% | 76 | 17.25M |
| 518 | QNRX | Quoin Pharmaceuticals, Ltd. | 15.14M | -2.06% | 7,690 | - |
| 519 | ALLR | Allarity Therapeutics, Inc. | 15.11M | 4.76% | 22,288 | - |
| 520 | CRIS | Curis, Inc. | 14.61M | 4.63% | 2,821 | 11.65M |
| 521 | NCNA | NuCana plc | 14.48M | -2.11% | 6,125 | - |
| 522 | KZIA | Kazia Therapeutics Limited | 14.46M | 5.35% | 35,807 | 1.20M |
| 523 | NCEL | NewcelX Ltd. | 14.27M | -0.63% | 339 | - |
| 524 | CLSD | Clearside Biomedical, Inc. | 14.08M | 3.07% | 868 | 3.33M |
| 525 | KAPA | Kairos Pharma, Ltd. | 13.90M | -2.43% | 7,605 | - |
| 526 | DWTX | Dogwood Therapeutics, Inc. | 13.74M | 0.67% | 1,358 | - |
| 527 | BCTX | BriaCell Therapeutics Corp. | 13.69M | - | 219 | - |
| 528 | BCDA | BioCardia, Inc. | 13.69M | 0.78% | 1,977 | 3.00K |
| 529 | SNGX | Soligenix, Inc. | 12.91M | 0.79% | 22,326 | 2.34K |
| 530 | LGVN | Longeveron Inc. | 12.84M | -0.27% | 31,108 | 1.44M |
| 531 | CLRB | Cellectar Biosciences, Inc. | 12.64M | 5.67% | 11,654 | - |
| 532 | CMMB | Chemomab Therapeutics Ltd. | 12.62M | 0.41% | 10,997 | - |
| 533 | COCP | Cocrystal Pharma, Inc. | 12.54M | -1.09% | 3,924 | - |
| 534 | EDSA | Edesa Biotech, Inc. | 12.18M | - | 193 | - |
| 535 | PHIO | Phio Pharmaceuticals Corp. | 12.06M | -5.88% | 125,294 | - |
| 536 | GOVX | GeoVax Labs, Inc. | 11.75M | -1.42% | 57,312 | 3.35M |
| 537 | VYNE | VYNE Therapeutics Inc. | 11.49M | -0.92% | 39,369 | 524.00K |
| 538 | IMRN | Immuron Limited | 11.32M | -2.17% | 2,537 | 4.78M |
| 539 | ICU | SeaStar Medical Holding Corporation | 11.26M | 0.77% | 115,332 | 881.00K |
| 540 | IMNN | Imunon, Inc. | 10.93M | -3.52% | 3,821 | - |
| 541 | APM | Aptorum Group Limited | 10.91M | -6.29% | 14,895 | - |
| 542 | SNSE | Sensei Biotherapeutics, Inc. | 10.81M | -2.61% | 1,101 | - |
| 543 | EVGN | Evogene Ltd. | 10.41M | 5.09% | 7,402 | 8.02M |
| 544 | CELZ | Creative Medical Technology Holdings, Inc. | 10.28M | 1.83% | 538 | 6.00K |
| 545 | PPCB | Propanc Biopharma, Inc. | 10.25M | -3.35% | 13,945 | - |
| 546 | ADXN | Addex Therapeutics Ltd | 10.12M | - | 1,429 | 210.35K |
| 547 | ERNA | Ernexa Therapeutics Inc. | 9.81M | -2.34% | 13,891 | 1,000.00 |
| 548 | BIVI | BioVie Inc. | 9.56M | -0.12% | 7,243 | - |
| 549 | CLDI | Calidi Biotherapeutics, Inc. | 9.51M | -5.80% | 20,231 | - |
| 550 | BRTX | BioRestorative Therapies, Inc. | 9.50M | -3.56% | 31,481 | 383.40K |
| 551 | AEON | AEON Biopharma, Inc. | 9.43M | -1.22% | 15,688 | - |
| 552 | BOLT | Bolt Biotherapeutics, Inc. | 9.21M | - | - | 5.20M |
| 553 | ACXP | Acurx Pharmaceuticals, Inc. | 8.72M | 6.91% | 3,469 | - |
| 554 | MBIO | Mustang Bio, Inc. | 8.47M | 0.87% | 4,040 | - |
| 555 | XTLB | XTL Biopharmaceuticals Ltd. | 8.39M | -1.39% | 1,279 | 451.00K |
| 556 | ENTO | Entero Therapeutics, Inc. | 8.07M | -3.61% | 10,701 | - |
| 557 | ALZN | Alzamend Neuro, Inc. | 7.72M | 3.05% | 5,653 | - |
| 558 | PHGE | BiomX Inc. | 7.69M | -3.64% | 130,210 | - |
| 559 | INAB | IN8bio, Inc. | 7.55M | 2.52% | 2,825 | - |
| 560 | TCRT | Alaunos Therapeutics, Inc. | 7.52M | -5.07% | 1,033 | 6.00K |
| 561 | GTBP | GT Biopharma, Inc. | 7.34M | -2.09% | 94,823 | - |
| 562 | RNAZ | TransCode Therapeutics, Inc. | 7.12M | -0.23% | 528 | - |
| 563 | PLRZ | Polyrizon Ltd. | 7.12M | 2.72% | 14,906 | - |
| 564 | TOVX | Theriva Biologics, Inc. | 6.95M | -3.87% | 134,902 | - |
| 565 | APRE | Aprea Therapeutics, Inc. | 6.94M | -0.90% | 2,551 | 488.24K |
| 566 | ADIL | Adial Pharmaceuticals, Inc. | 6.88M | -3.92% | 1,101,826 | - |
| 567 | PPBT | Purple Biotech Ltd | 6.66M | -3.60% | 10,476 | - |
| 568 | KPRX | Kiora Pharmaceuticals, Inc. | 6.60M | - | 2,922 | 20.00K |
| 569 | BGMS | Bio Green Med Solution, Inc. | 6.22M | 3.25% | 3,975 | 81.00K |
| 570 | ENSC | Ensysce Biosciences, Inc. | 5.88M | 3.11% | 13,679 | 4.49M |
| 571 | MTNB | Matinas BioPharma Holdings, Inc. | 5.57M | 3.45% | 167 | - |
| 572 | LYRA | Lyra Therapeutics, Inc. | 5.56M | - | 15 | 600.00K |
| 573 | CYCN | Cyclerion Therapeutics, Inc. | 5.52M | 2.11% | 2,718 | 2.86M |
| 574 | VIVS | VivoSim Labs, Inc. | 5.45M | -3.69% | 1,853 | 140.00K |
| 575 | XBIO | Xenetic Biosciences, Inc. | 5.32M | 0.43% | 6,936 | 2.86M |
| 576 | REVB | Revelation Biosciences, Inc. | 5.20M | 3.27% | 536 | - |
| 577 | GNPX | Genprex, Inc. | 5.06M | -1.90% | 21,351 | - |
| 578 | GRI | GRI Bio, Inc. | 4.85M | -5.39% | 24,110 | - |
| 579 | SILO | Silo Pharma, Inc. | 4.84M | -0.03% | 16,926 | 72.10K |
| 580 | JAGX | Jaguar Health, Inc. | 4.76M | 2.85% | 9,908 | 11.79M |
| 581 | ASBP | Aspire Biopharma Holdings, Inc. | 4.58M | -5.32% | 4,188,245 | 1.94K |
| 582 | KALA | KALA BIO, Inc. | 4.53M | -0.57% | 4,114 | - |
| 583 | CDIO | Cardio Diagnostics Holdings, Inc. | 4.51M | -0.40% | 639 | 15.78K |
| 584 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.36M | 1.98% | 2,791 | 1.36M |
| 585 | HCWB | HCW Biologics Inc. | 4.36M | 5.30% | 1,333 | 422.03K |
| 586 | AIXC | AIxCrypto Holdings, Inc. | 4.34M | -2.66% | 41,287 | - |
| 587 | PMCB | PharmaCyte Biotech, Inc. | 4.33M | 1.14% | 2,983 | - |
| 588 | GLMD | Galmed Pharmaceuticals Ltd. | 4.22M | -5.39% | 106,361 | - |
| 589 | PTIX | Protagenic Therapeutics, Inc. | 3.81M | -1.49% | 5,112 | - |
| 590 | SPRC | SciSparc Ltd. | 3.77M | -1.06% | 4,788 | 927.00K |
| 591 | OGEN | Oragenics, Inc. | 3.75M | -1.38% | 9,628 | - |
| 592 | CNSP | CNS Pharmaceuticals, Inc. | 3.74M | - | 169 | - |
| 593 | ONCO | Onconetix, Inc. | 3.59M | -1.29% | 469 | 1.22M |
| 594 | ELAB | PMGC Holdings Inc. | 3.43M | -3.35% | 947 | -241.53K |
| 595 | ARTL | Artelo Biosciences, Inc. | 3.38M | -2.18% | 4,860 | - |
| 596 | SLRX | Salarius Pharmaceuticals, Inc. | 3.26M | 2.74% | 20,285 | - |
| 597 | PBM | Psyence Biomedical Ltd. | 3.22M | - | 262,530 | - |
| 598 | AZTR | Azitra, Inc. | 3.16M | -2.82% | 29,029 | 7.50K |
| 599 | XRTX | XORTX Therapeutics Inc. | 3.13M | 0.19% | 3,218 | - |
| 600 | INDP | Indaptus Therapeutics, Inc. | 3.08M | 0.57% | 7,315 | - |
| 601 | ENVB | Enveric Biosciences, Inc. | 3.03M | - | 358 | - |
| 602 | SCNI | Scinai Immunotherapeutics Ltd. | 2.87M | -1.26% | 7,389 | 1.15M |
| 603 | CDT | CDT Equity Inc. | 2.69M | -0.60% | 4,478 | - |
| 604 | BDRX | Biodexa Pharmaceuticals Plc | 2.43M | -0.25% | 1,244 | 104.90K |
| 605 | KTTA | Pasithea Therapeutics Corp. | 2.31M | -25.30% | 933,823 | - |
| 606 | MLEC | Moolec Science SA | 1.89M | 0.28% | 7,035 | 7.83M |
| 607 | VRAX | Virax Biolabs Group Limited | 1.74M | - | 6,820 | 6.33K |
| 608 | DRMA | Dermata Therapeutics, Inc. | 1.68M | -1.60% | 3,776 | - |
| 609 | SLXN | Silexion Therapeutics Corp | 1.34M | 1.70% | 12,470 | - |
| 610 | CMND | Clearmind Medicine Inc. | 1.11M | 2.54% | 978,796 | - |
| 611 | ADTX | Aditxt, Inc. | 119.35K | -5.57% | 18,716 | 5.95K |